Medtech Patent Position Might Be Shakier As Supreme Court Seems To Favor IPR Standard
This article was originally published in The Gray Sheet
Executive Summary
Chief Justice John Roberts criticizes broad interpretation of patent terms in inter partes reviews, but he seems to be in the minority.